Your browser doesn't support javascript.
loading
Preoperative bevacizumab does not increase complications following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
King, Bradley H; Baumgartner, Joel M; Kelly, Kaitlyn J; Marmor, Rebecca A; Lowy, Andrew M; Veerapong, Jula.
Afiliação
  • King BH; School of Medicine, University of California, San Diego, La Jolla, California, United States of America.
  • Baumgartner JM; Division of Surgical Oncology, Department of Surgery, University of California, San Diego, La Jolla, California, United States of America.
  • Kelly KJ; Division of Surgical Oncology, Department of Surgery, University of California, San Diego, La Jolla, California, United States of America.
  • Marmor RA; Division of Surgical Oncology, Department of Surgery, University of California, San Diego, La Jolla, California, United States of America.
  • Lowy AM; Division of Surgical Oncology, Department of Surgery, University of California, San Diego, La Jolla, California, United States of America.
  • Veerapong J; Division of Surgical Oncology, Department of Surgery, University of California, San Diego, La Jolla, California, United States of America.
PLoS One ; 15(12): e0243252, 2020.
Article em En | MEDLINE | ID: mdl-33270763

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Procedimentos Cirúrgicos de Citorredução / Bevacizumab / Quimioterapia Intraperitoneal Hipertérmica Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Procedimentos Cirúrgicos de Citorredução / Bevacizumab / Quimioterapia Intraperitoneal Hipertérmica Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article